DRKS00013229
Recruiting
Not Applicable
Gene expression in psoriasis - Post-analyses of the PSORITUS study - Post-analyses of PSORITUS study
Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster0 sites20 target enrollmentOctober 26, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- L40.0
- Sponsor
- Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with psoriasis vulgaris (L40\.0\) without pruritus (group 1\) and with pruritus (group 2, historical control group from the Psoritus study)
Exclusion Criteria
- •Patients younger than 18 years. Patients who cannot complete the questionnaires due to physical or psychiatric diseases. Patients with reduced consciousness. Patients who don't understand German.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Epigenetic biomarkers to predict psoriasis disease progression * towards tailored therapy.psoriasisskin disease with fast proliferation and less differentiation of skin cells1004078910011063NL-OMON40335Maastricht Universitair Medisch Centrum +9
Active, not recruiting
Phase 1
Study in patients with moderate to severe psoriasis with secukinumabEUCTR2014-002212-16-DEovartis Pharma GmbH
Completed
Not Applicable
Predictors of psoriasis on response to systemic therapyL40PsoriasisDRKS00017896AbbVie Deutschland GmbH & Co. KG381
Unknown
Phase 3
M518101 phase III study in plaque psoriasis patientsPlaque psoriasisJPRN-jRCT2080222894Maruho Co.,Ltd.
Completed
Not Applicable
Exploring biomarkers in pediatric psoriasis: non-invasive measurement by Transdermal Analyses PatchesChronic skin diseasePsoriasis10014982NL-OMON45371Dermatologie42